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igration of epithelial cells is essential for tissue
morphogenesis, wound healing, and metastasis of
epithelial tumors. Here we show that ARNO, a
guanine nucleotide exchange factor for ADP-ribosylation
factor (ARF) GTPases, induces Madin-Darby canine kidney
epithelial cells to develop broad lamellipodia, to separate
from neighboring cells, and to exhibit a dramatic increase
in migratory behavior. This transition requires ARNO cata-
lytic activity, which we show leads to enhanced activation
of endogenous ARF6, but not ARF1, using a novel pull-
down assay. We further demonstrate that expression of
M
 
ARNO leads to increased activation of endogenous Rac1,
and that Rac activation is required for ARNO-induced cell
motility. Finally, ARNO-induced activation of ARF6 also re-
sults in increased activation of phospholipase D (PLD), and
inhibition of PLD activity also inhibits motility. However, in-
hibition of PLD does not prevent activation of Rac. Together,
these data suggest that ARF6 activation stimulates two dis-
tinct signaling pathways, one leading to Rac activation, the
other to changes in membrane phospholipid composition,
and that both pathways are required for cell motility.
 
Introduction
 
Columnar epithelia grow as sheets of cells in which neighbor-
ing cells are attached to each other by junctional complexes,
including tight junctions and adherens junctions. In tissues,
epithelial cells are normally stationary and nonmigratory,
however, during embryonic development, wound healing, or
metastasis of tumors they may become migratory (Gumbiner,
1996; Schmitz et al., 2000). The adoption of a motile pheno-
type requires regulated changes in the actin cytoskeleton and
in the attachment of cells to the substratum. Small GTPases
of the Rho family are intimately involved in regulating these
processes (for review see Schmitz et al., 2000). Recent work
has demonstrated that members of the ADP-ribosylation fac-
tor (ARF)* family of small GTPases can also regulate assembly
of the actin cytoskeleton (Radhakrishna et al., 1996; D’Souza-
Schorey et al., 1997; Norman et al., 1998; Radhakrishna et
al., 1999; Zhang et al., 1999; Boshans et al., 2000).
Like Rho GTPases, ARFs are members of the Ras super-
family and have been well characterized as regulators of vesic-
ular transport. The six known ARF isoforms can be divided
into three classes. Class 1 ARFs (ARFs 1–3) regulate traffick-
ing in the secretory pathway and in endosomes. Very little is
known about the role of class II ARFs (ARFs 4 and 5). The
sole class III ARF, ARF6, functions in the endosomal plasma
membrane system, and has been shown to regulate traffick-
ing between these compartments (for review see Chavrier
and Goud, 1999).
It is becoming increasingly clear that modulation of actin
assembly is an important function of ARF proteins. For ex-
ample, ARF1 has recently been shown to regulate the re-
cruitment of paxillin into focal adhesions (Norman et al.,
1998). Activation of ARF6 also results in reorganization of
the cortical actin cytoskeleton (Radhakrishna et al., 1996;
D’Souza-Schorey et al., 1997). Several studies have sug-
gested an intimate connection between ARF6 and the Rho
family of small GTPases; however, the precise relationship
is poorly understood (D’Souza-Schorey et al., 1997; Rad-
hakrishna et al., 1999; Zhang et al., 1999; Boshans et al.,
2000).
Like all GTPases, ARFs are switches that are active when
bound to GTP and inactive when bound to GDP. Intercon-
version of the two states requires the activity of several acces-
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sory proteins. Guanine nucleotide exchange factors (GEFs)
catalyze the release of bound GDP and its subsequent re-
placement by GTP, leading to ARF activation. Similarly, a
return to the inactive state requires hydrolysis of the bound
GTP to GDP, which is facilitated by the GTPase activating
proteins (GAPs) (Donaldson and Jackson, 2000).
ARNO is a member of one subfamily of ARF-GEFs,
which also includes cytohesin-1, GRP-1, and ARNO/cyto-
hesin-4, all of which share a similar domain organization
(for review see Jackson and Casanova, 2000). The NH
 
2
 
-ter-
minal 60 amino acids comprise a coiled coil domain that
mediates homodimerization. A central catalytic domain, the
Sec7 domain, is a conserved feature of all ARF-GEFs. Muta-
tion of a key residue within this domain (E156K in ARNO)
completely abrogates the exchange activity of all Sec7 family
members tested to date (Beraud-Dufour et al., 1998). The
COOH-terminal portion of the protein contains a PH do-
main and a polybasic domain that mediate the interaction
of these proteins with membrane surfaces (Jackson and
Casanova, 2000).
ARNO family members can catalyze exchange on multi-
ple ARF isoforms in vitro. Therefore, it is likely that colocal-
ization of these proteins with a specific ARF isoform is the
primary determinant of their substrate specificity (Chardin
et al., 1996; Frank et al., 1998a; Langille et al., 1999). En-
dogenous ARNO has been localized to the plasma mem-
brane of BHK cells (Frank et al., 1998a), adrenal chromaffin
cells (Caumont et al., 2000), and to the apical pole of kid-
ney-proximal tubule epithelial cells (Maranda et al., 2001).
Additionally, exogenous ARNO can be seen to colocalize
with ARF6 at the plasma membrane (Frank et al., 1998a), is
recruited to the plasma membrane in response to PI-
(3,4,5)P
 
3
 
 production (Venkateswarlu et al., 1998), and can
stimulate actin cytoskeletal rearrangements (Frank et al.,
1998b). Because of the relative enrichment of ARF6 at the
plasma membrane and in the endosomal system (Peters et
al., 1995), we and others have suggested that ARF6 is likely
to be the primary substrate for ARNO in vivo (Frank et al.,
1998a,b; Caumont et al., 2000). However, the ability of
ARF1 to regulate focal adhesion assembly suggests that
ARF1 may also have some role at the plasma membrane
(Norman et al., 1998). No matter which ARF is involved, it
is clear that ARNO is a key regulator of ARF function at the
cell surface.
It has been shown recently that in polarized epithelial cells
and tissues ARF6, like ARNO, is concentrated at or near the
apical plasma membrane (Marshansky et al., 1997; Maranda
et al., 2001). Additionally, ARF6 has been shown to selec-
tively regulate apical endocytosis in MDCK cells (Altschuler
et al., 1999). Therefore, we were interested in investigating
the role of ARNO and ARF6 in modulating the actin cy-
toskeleton in epithelial cells.
We found that expression of ARNO in MDCK cells leads
to a profound change in cell morphology and behavior. The
cells rapidly form large fan-shaped lamellipodia and pull
away from the tightly joined islands of cells that are charac-
teristic of this cell line. Consistent with this morphological
change, ARNO-expressing cells exhibit increased migratory
activity in both a Boyden chamber migration assay and in a
wound healing assay. We show that ARNO expression leads
to activation of endogenous Rac1, and that Rac activity is re-
quired for acquisition of the migratory phenotype. This
transition also requires activation of a known ARF effector,
phospholipase D (PLD). However, PLD activity is not re-
quired for Rac activation, indicating that Rac and PLD lie
on two distinct signaling pathways downstream of ARF, and
function in concert to convert epithelial cells from a station-
ary to a migratory state. Therefore, ARF proteins may play a
much more significant role in the regulation of cell motility
than has previously been appreciated.
 
Results
 
Expression of ARNO induces migration of MDCK cells
 
To examine regulation of epithelial actin structure, we have
taken advantage of a recombinant adenovirus system that ex-
presses proteins under the control of a tetracycline-regulat-
able promoter (Altschuler et al., 1999). Infection of MDCK
cells expressing the tetracycline-regulatable transactivator
(T23 MDCK; Barth et al., 1997) with these adenoviruses re-
sults in rapid and robust expression of the encoded trans-
gene. All controls are infected with the virus in the presence
of 20 ng/ml doxycycline, which prevents transgene expres-
sion, to control for any possible effects of viral infection.
When grown at subconfluent density, MDCK cells nor-
mally form compact islands of cells with tight junctions and
adherens junctions between adjacent cells. Cells shown in
Fig. 1 A were infected for 3 h with adenovirus encoding
myc-tagged wild-type ARNO in the presence of doxycy-
cline, and appear identical to noninfected cells (data not
shown). After 3 h of infection with the same virus in the ab-
sence of doxycycline, expression of ARNO is readily appar-
ent (Fig. 1 B). Moreover, ARNO-expressing cells on the
edges of the island form large, fan-shaped lamellae and begin
to pull away from their neighbors. Intriguingly, ARNO-
expressing cells located in the interior of the islands do not
manifest this altered morphology and remain firmly at-
tached to their neighbors (Fig. 1 B). Importantly, a point
mutant of ARNO, E156K, which lacks nucleotide exchange
activity, does not induce the formation of lamellipodia or
separation from the cell cluster, even in cells at the margins
(Fig. 1 C). Together, these data suggest that activation of
ARF is required for the ARNO-induced changes in epithe-
lial morphology and behavior.
To investigate whether ARNO makes MDCK cells more
migratory, we used a transwell migration assay. MDCK cells
were infected with an adenovirus encoding either wild-type
ARNO in the presence or absence of doxycycline, or with
the catalytically inactive point mutant E156K. The cells
were placed in the upper chamber of transwell filters that
had been coated on the underside with fibronectin, and al-
lowed to migrate for 16 h. As shown in Fig. 2, 
 
 
 
2% of con-
trol cells migrated through the filter, whereas expression of
ARNO led to an eightfold increase in the number of mi-
grated MDCK cells. The catalytically inactive E156K mu-
tant yielded results that were indistinguishable from con-
trols, indicating that activation of ARF is a key element of
this migratory behavior.
To more directly observe the effect of ARNO on the mi-
gratory behavior of MDCK cells, we used time lapse video 
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microscopy to examine cells in a wound-healing assay.
When MDCK cells become confluent, they form a mono-
layer and adopt a typical columnar epithelial morphology.
Disruption of the monolayer by dragging a Teflon cell
scraper through the culture causes cells on the edge of the
wound to rapidly spread and become flattened, rather than
columnar. As these cells migrate into the wounded area,
ranks of cells located further back from the wound edge
are successively recruited to begin spreading. The leading
wound edge migrates smoothly as a unit; the cells in this
edge remain attached to adjacent cells and do not pull away
from the monolayer (Fig. 3, A–C, and Video 1 [available at
www.jcb.org/cgi/content/full/200104019/DC1]).
Monolayers of cells expressing ARNO have noticeably dif-
ferent morphology and behavior. The leading edge does not
move forward as a smooth unit. These cells pull away from
the wound edge and exhibit a distinct fan-shaped, leading
edge and a trailing edge with a tail that often remains at-
tached to the body of the monolayer (Fig. 3, D–F, and Video
2 [available at www.jcb.org/cgi/content/full/200104019/
DC1]). This morphology is similar to that seen in islands
(Fig. 1 B). Immunofluorescence microscopy of wounded
monolayers revealed that these cells are indeed expressing
ARNO (data not shown). We quantified the effects of
ARNO expression on migration by measuring the area cov-
ered by the migrating monolayer over time (see Materials
and methods). As shown in Fig. 3 J, expression of ARNO
significantly increased the rate of migration of the mono-
layer into the wound.
We have demonstrated previously that phosphorylation of
ARNO at a single serine residue (S392) reduces the affinity
of ARNO for membranes and may be a mechanism for
downregulation of ARNO activity (Santy et al., 1999).
Therefore, we reasoned that a mutant of ARNO containing
both the inactivating point mutation, E156K, and a muta-
tion of the phosphorylated serine, S392A, might be an effec-
tive dominant inhibitory molecule. This mutant should be
Figure 1. Expression of catalytically active ARNO induces migra-
tory morphology in MDCK cells. MDCK cells were cultured on 
glass coverslips, infected with adenovirus encoding ARNO under 
the control of the tetracycline regulatable transactivator for 3 h, and 
processed for immunofluorescence microscopy as described in Ma-
terials and methods. Cells were stained with 9E10 monoclonal anti-
myc (green) to label ARNO and rhodamine-conjugated phallodin to 
label filamentous actin. (A) Control cells infected in the presence of 
doxycycline to prevent transgene expression, (B) cells expressing 
myc-tagged wild-type (WT) ARNO, (C) cells expressing myc-tagged 
catalytically inactive ARNO E156K. Bar, 50  m.
Figure 2. Expression of ARNO enhances the migration of MDCK 
cells in a modified Boyden chamber migration assay. MDCK cells 
were infected for 4 h with virus encoding wild-type ARNO, E156K 
ARNO in the presence (control) or absence of doxycycline. Cells 
were harvested and placed in transwell filter chambers coated on 
the underside with fibronectin (see Materials and methods). Cells 
were then allowed to migrate for 16 h and quantitated as described 
in Materials and methods. Data shown are mean   standard devia-
tion of triplicate samples and are representative of  10 experiments. 
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recruited to sites of ARNO action but remain membrane-
bound, inhibiting recruitment of endogenous ARNO and
preventing activation of ARFs. Indeed, we found that ex-
pression of this E156K-S392A mutant inhibited migration
of MDCK monolayers in the wound healing assay. Very lit-
tle spreading of cells is observed, and few if any ruffles form
at the wound edge. Additionally, cells further back from the
wound edge remain unspread and movement of the epithe-
lial sheet into the wound is slowed (Fig. 3, G–J, and Video
 
3 [available at www.jcb.org/cgi/content/full/200104019/
DC1]). These data suggest that activation of ARF proteins
by ARNO is critically important for the migration of
MDCK epithelial sheets into a wound.
 
ARNO selectively activates ARF6
 
Because ARNO is relatively promiscuous in its substrate
specificity in vitro, we investigated the localization of endog-
enous MDCK ARF proteins in ARNO-expressing cells us-
ing immunofluorescence microscopy. Endogenous ARF6
was observed throughout the large lamellipodia and ap-
peared to be concentrated at the leading edge of migrating
cells, where it colocalized with ARNO (Fig. 4, C and D).
ARF1, in contrast, could be seen in a perinuclear crescent re-
sembling the Golgi and in other locations throughout the
cell, but was barely detectable within the ruffle or at the
leading edge (Fig. 4, A and B).
We also tested the ability of ARNO to activate endoge-
nous MDCK ARF1 or ARF6 using a novel pull down assay.
This assay is analogous to the widely used assays in which
glutathione 
 
S
 
-transferase (GST) fused to fragments of p21-
activated kinase (PAK) are used to selectively precipitate
GTP-bound Rac and Cdc42 from cells (Benard et al.,
1999). Here, we took advantage of the GTP-dependent
interaction of ARF with the GGAs (Golgi-localized, 
 
 
 
 ear–
containing ARF-binding proteins), a family of recently
described ARF effector proteins (Boman et al., 2000;
Dell’Angelica et al., 2000; Hirst et al., 2000). To selectively
precipitate GTP-bound ARFs, we used a GST fusion con-
taining the VHS and ARF binding domains of GGA3
(GST-GGA). The specificity of this assay was tested using
MDCK cells expressing GTP-binding state mutants of ARF1
and ARF6. As is shown in Fig. 4 E, only the mutationally
activated, GTP-bound mutants of ARF1 (ARF1Q71L) and
ARF6 (ARF6Q67L) bound to GST-GGA, whereas the
GDP-bound dominant negative mutants (ARF1T31N,
ARF6T27N) did not. To measure the activation of endoge-
nous ARFs, GST-GGA was incubated with lysates of
MDCK cells. The bound, active ARFs were isolated and vi-
sualized by Western blotting with ARF1- and ARF6-specific
antibodies. The amount of GTP-ARF was compared with
the total amount of ARF present in the initial lysate and
quantitated by densitometry.
After adenovirus-mediated expression of ARNO for only
2–3 h, which is sufficient to induce the ARNO-specific mor-
phological changes described above, the activation of endog-
enous ARF1 and ARF6 in the same sample was determined
and compared with activation levels in control cells (Fig. 4
F). Although the extent of ARF activation by ARNO varied
between experiments, pairwise comparison of ARF6 versus
ARF1 isolated from the same samples in nine experiments
demonstrates that ARNO expression activates ARF6 (2.1 
 
 
 
0.84-fold) selectively over ARF1 (1.0 
 
 
 
 0.27-fold; paired 
 
t
 
test ARF6 versus ARF1; 
 
P
 
 
 
  
 
0.001). Although it is possible
that activation of a small pool of peripheral ARF1 by ARNO
is responsible for the modulation of morphology, these data
are most consistent with the idea that ARNO induces the
observed changes by enhancing levels of GTP-ARF6.
To further investigate the ability of ARF6 to regulate mi-
gration, we observed the effect of the dominant negative
Figure 3. Migration of MDCK cells in a wound healing assay is al-
tered by expression of wild-type ARNO or the catalytically inactive 
mutant E156K-S392A. Confluent MDCK monolayers were infected 
with recombinant adenovirus and wounded as described in Materi-
als and methods. Control cells (A–C), wild-type ARNO–expressing 
cells (D–F), or E156K-S392A ARNO–expressing cells (G–I) were ob-
served migrating into the wound by time lapse video microscopy. 
Frames shown were taken 0 h (A, D, and G), 2 h (B, E, and H), or
4 h (C, F, and I) after wounding. Video frames were recorded every 
minute for 4 h and videos are available at www.jcb.org/cgi/content/
full/200104019/DC1. (J) ARNO alters the rate of migration into the 
wound. The surface area covered by the migrating monolayer was 
measured using the program OpenLab and the increase in monolayer 
area over time is shown. Data shown are mean   standard deviation 
of eight (ARNO), six (control), and three (E156K-S392A) individual 
experiments. Data were evaluated using the Student’s t test. Asterisk 
indicates P   0.05; double asterisk indicates P   0.01. Bar, 100  m. 
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ARF6 mutant, T27N, on migration of MDCK cells. Mono-
layers of MDCK cells were infected with adenovirus encod-
ing ARF6 T27N and incubated overnight in the presence of
0.2 ng/ml dox before migration was tested using the wound
healing assay. Under these conditions, the dominant nega-
tive ARF6 is overexpressed to levels less than fivefold over
the endogenous protein (Altschuler et al., 1999, and data not
shown). Expression of ARF6 T27N significantly inhibited
the migration of MDCK cell monolayers in the wound heal-
ing assay (Fig. 4 G). These data further support the idea that
activation of ARF6 enhances migration of MDCK cells.
 
Stimulation of migration by ARNO 
requires activation of Rac
 
The large lamellipodia induced by ARNO are similar in
morphology to those induced by activation of Rac. Addi-
tionally Rac activity has been shown to be required for
wound healing in monolayers of MDCK cells (Fenteany et
al., 2000) or fibroblasts (Nobes and Hall, 1999). To assess
the activation state of endogenous Rac, we used a GST fu-
sion to the p21 binding domain of PAK in a pulldown assay.
Lysates of control cells, cells expressing wild-type ARNO, or
cells expressing ARNO E156K were incubated with GST-
PAK and the relative amounts of Rac-GTP in each lysate
were analyzed by Western blotting. As shown in Fig. 5, cells
expressing wild-type ARNO contained significantly more
active Rac than the control cells (average activation 2.2-fold,
paired 
 
t
 
 test; 
 
P
 
 
 
  
 
0.008, 
 
n
 
 
 
  
 
11). In contrast, cells express-
ing the E156K mutant contained levels of Rac-GTP similar
to controls (Fig. 5, average activation 0.84-fold, paired 
 
t
 
 test;
 
P
 
 
 
  
 
0.19, 
 
n
 
 
 
  
 
6). Because ARNO is selective for ARFs and
is unable to activate Rac directly in vitro (Chardin et al.,
1996; Casanova, J.E., unpublished data), these observations
suggest that ARF activation by ARNO leads to the down-
stream activation of Rac.
To investigate whether Rac activation is required for
ARNO-induced migratory effects, we examined the ability
of a dominant negative mutant of Rac (N17) to block these
changes. In contrast to control cells expressing ARNO alone
(Fig. 6, A and B), MDCK cells expressing both N17-Rac
and ARNO failed to extend lamellipodia and remained
firmly attached to their neighbors (Fig. 6, C and D). Addi-
tionally, coexpression of N17-Rac with ARNO blocks the
migratory morphology seen in cells expressing ARNO alone
during wound healing (data not shown). These data suggest
that activation of Rac downstream of ARF is indeed neces-
sary for ARNO-induced cell migration.
 
Activation of PLD correlates with ARNO-induced 
cell motility
 
To explore signal transduction pathways leading from
ARNO to Rac activation and motility, we investigated the
role of one well-characterized downstream ARF effector,
PLD, which converts phosphatidylcholine into phosphatidic
acid (PA) (Exton, 1997). As shown in Fig. 7, expression of
ARNO in MDCK cells increased PLD activity 2.6-fold. This
increase was dependent upon ARNO catalytic activity, as the
E156K point mutant did not stimulate PLD activity (Fig. 7).
Figure 4. Association of ARNO with endogenous ARF6 in MDCK 
cells. (A–D) Cells were infected with adenovirus encoding myc-
tagged ARNO for 3 h. Cells were labeled with 9E10 monoclonal 
anti-myc (A and C) and rabbit polyclonal antisera specific for either 
ARF1 (B) or ARF6 (D). E,F: Affinity precipitation of active ARFs using 
GST-GGA. To demonstrate the specificity of GST-GGA for ARF-GTP, 
MDCK cells were infected with adenovirus encoding HA-tagged 
constitutively active (ARF6Q67L, ARF1Q71L) or dominant negative 
(ARF6T27N, ARF1T31N) ARF mutants (E). Cells were lysed and GTP-
bound ARF was isolated as described in Materials and methods. To 
measure activation of endogenous ARFs (F), cells were infected with 
adenovirus encoding wild-type ARNO in the presence (control) or 
absence (ARNO) of doxycycline. Cells were lysed and precipitated 
with GST-GGA as in E. Arfs were quantitated by Western blotting 
with monoclonal anti-HA (E) or ARF1- and ARF6-specific antibodies 
(F). Data shown in F are representative of nine experiments. (G) 
ARF6 T27N inhibits migration into the wound. Confluent monolay-
ers of MDCK cells were infected with adenovirus encoding ARF6 
T27N and incubated overnight in the presence of 20 ng/ml doxycy-
cline (Control) or 0.2 ng/ml doxycycline (ARF6 T27N) and wound 
healing was performed as in the legend to Fig. 3. Data shown are 
mean   standard deviation of four (control) or six (ARF6 T27N) in-
dividual experiments. Data were evaluated using the Student’s t test. 
Double asterisk indicates P   0.01. Bar, 20  m. 
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Next, we investigated the effect of PLD inhibition on the
morphology of ARNO-expressing cells. PLD can utilize pri-
mary alcohols in the place of H
 
2
 
O during the hydrolysis
of phosphatidylcholine, producing a phosphatidylalcohol,
rather than phosphatidic acid (Exton, 1997). The produc-
tion of this alternate product disrupts further signaling
downstream of PLD that requires PA. Secondary and ter-
tiary alcohols cannot be used by PLD and therefore can be
used to control for other nonspecific effects of alcohol on
cells. We analyzed the morphology of ARNO-expressing
cells upon treatment with 0.5% 1-butanol (Fig. 8, C and D)
or, as a control, tert-butanol (Fig. 8, E and F). Treatment
with 1-butanol inhibits formation of the large fan-shaped
lamellipodia characteristic of ARNO-expressing cells. The
only ruffle-like structures seen in these cells are very small
protrusions seen at the edges of ARNO-expressing cells on
the margins of the islands. Additionally, these cells remain
firmly attached to the island. In contrast, ARNO-expressing
cells treated with tert-butanol display large lamellipodia and
separate from their neighbors, similarly to cells in the ab-
sence of butanol (Fig. 8, E and F).
 
Activation of Rac by ARNO does not require 
PLD activity
 
Because acquisition of the migratory phenotype required ac-
tivation of both Rac1 and PLD, we examined whether acti-
vation of Rac was dependent on PLD and production of
PA. MDCK cells were infected with adenovirus encoding
ARNO for 2 h. Further expression was stopped with the ad-
dition of doxycycline, and 0.5% 1-butanol or tert-butanol
was added to the incubation medium. After an additional
1 h of incubation, the activation state of Rac was deter-
mined. As can be seen in Fig. 9, addition of butanol had no
detectable effect on the activation of Rac by ARNO under
these conditions. It is possible that during the initial expres-
sion period enough PA was generated by the action of ARF
on PLD to stimulate the activation of Rac, and that the sub-
sequent addition of butanol did not sufficiently reduce PA
levels in the cells. We were unable to test this possibility, as
inclusion of 1-Butanol during the entire infection period se-
verely inhibited expression of exogenous ARNO from the
adenovirus construct (Santy, L.C., unpublished data). Nev-
ertheless, as far as we were able to determine, PA production
by PLD is not necessary for Rac activation, although it is re-
quired for ARNO’s morphological and migratory effects.
 
Discussion
 
The migration of epithelial cells is central to several impor-
tant biological processes, including tissue morphogenesis,
wound healing, and metastasis (Gumbiner, 1996). GTPases
of the Rho family have been implicated as regulators of
the cytoskeletal reorganization associated with cell motility
(Schmitz et al., 2000). More recently, it has become clear
that members of the ARF GTPase family also function in
the regulation of cytoskeletal assembly, and may integrate
with Rho proteins in this process (Radhakrishna et al., 1996,
1999; D’Souza-Schorey et al., 1997; Zhang et al., 1999;
Boshans et al., 2000). In this study, we demonstrate that ac-
tivation of ARF through expression of the GEF ARNO pro-
duces profound changes in the shape and migratory poten-
tial of MDCK epithelial cells. Expression of ARNO in
subconfluent MDCK cultures causes cells at the edge of is-
lands to form large, fan-shaped lamellipodia and to become
significantly more migratory than nonexpressing cells. The
adoption of this motile phenotype is the result of ARNO-
mediated activation of ARF6 and the subsequent activation
of both PLD and Rac.
 
Induction of the migratory phenotype by ARNO
 
The ability of ARNO to induce a migratory phenotype is not
shared among all cells in the epithelial population. Only
MDCK cells with a free edge, either those at the edge of an is-
land of cells or those with a side exposed by wounding, ex-
hibit broad lamellipodia upon ARNO expression. As tight
junctions serve as barriers to the lateral diffusion of both pro-
teins and lipids in the plane of the membrane, cells with a free
edge (i.e., lacking junctions) cannot prevent the intermixing
Figure 5. Expression of ARNO leads to activation of endogenous 
Rac. MDCK cells were infected with adenovirus encoding ARNO in 
the presence (control) or absence (ARNO) of doxycycline or with vi-
rus encoding ARNO E156K. Cells were lysed and GTP-Rac was iso-
lated by incubation with a GST fusion containing the PBD domain 
of PAK as described in Materials and methods. Rac-GTP (top) and 
total Rac (bottom) were quantitated by Western blot. Data are repre-
sentative of 11 (ARNO) or 6 (E156K) experiments. 
ARNO-induced migration of MDCK cells |
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of apical and basolateral membrane constituents (Gumbiner,
1996). This leads to the creation of a novel membrane/cy-
toskeletal domain at the free edge of epithelial cells, where, for
example, adhesive interactions would occur predominantly
through integrins as opposed to cadherins. Recruitment of
ARNO into this location may bring together all the compo-
nents necessary for induction of the migratory phenotype.
Interaction of ARNO with membranes is thought to be pri-
marily mediated by binding of its PH domain to phospho-
inositides (Chardin et al., 1996; Klarlund et al., 2000). Accu-
mulation of phosphoinositides at the free edge could therefore
lead to preferential recruitment of ARNO to this location. In-
deed, a recent study of wound healing in MDCK monolayers
demonstrated a requirement for polyphosphoinositides in this
process (Fenteany et al., 2000). However, the subcellular lo-
calization of lipid binding sites may not entirely explain local-
ization of ARNO to the free edge, as it has recently been
shown that the coiled coil domain mediates the interaction of
ARNO family members with GRASP, a retinoic acid–induced
scaffolding protein (Nevrivy et al., 2000). Therefore, ARNO
may be concentrated at the free edge at least in part by inter-
action with a localized interacting protein.
Because ARNO is relatively promiscuous in vitro, it is
likely that its specificity in vivo depends largely on its intra-
cellular colocalization with specific ARF isoforms (Chardin et
al., 1996; Frank et al., 1998a). In this study, we demonstrate
that endogenous ARF6 is colocalized with ARNO in the
ARNO-induced lamellipodia, whereas endogenous ARF1 is
barely detectable in this location. Additionally, we examined
the activation of endogenous ARFs using a novel pulldown
assay, and demonstrate that exogenous ARNO stimulates a
specific activation of ARF6 relative to ARF1. Finally, we
demonstrate that expression of dominant negative ARF6
T27N can inhibit migration of MDCK cells. These findings
are consistent with the previously demonstrated peripheral
localization of both ARNO and ARF6, with the relative
paucity of ARF1 at the plasma membrane, and with the
well-documented effects of ARF6 activation on the cortical
actin cytoskeleton (Chavrier and Goud, 1999; Jackson and
Casanova, 2000).
 
ARF activation and downstream signaling
 
Our data demonstrate that activation of ARF6 by ARNO in
MDCK cells leads to the adoption of a migratory pheno-
Figure 6. N17 Rac expression blocks 
morphological changes induced by 
ARNO. MDCK cells expressing N17 Rac 
under the control of the tetracycline reg-
ulatable transactivator were either in-
duced to express for 18 h (C and D) or 
removed from doxycycline immediately 
before (A and B) being infected with 
ARNO encoding adenovirus. Cells were 
incubated for 3 h and then fixed and 
processed for immunofluorescence mi-
croscopy. Cells were stained with mono-
clonal anti-ARNO (A and C) and 
rhodamine phallodin (B and D). Aster-
isks indicate ARNO-expressing cells. 
Bar, 50  m.
Figure 7. ARNO expression increases PLD activity in MDCK cells. 
Control cells, cells expressing wild-type ARNO, or ARNO E156K 
were assayed for PLD activity by incorporation of labeled lipid into 
phosphatidylbutanol as described in Materials and methods. Data 
shown are mean   standard deviation of triplicate samples and are 
representative of  10 experiments. 
606 The Journal of Cell Biology 
 
|
 
 
 
Volume 154, 2001
 
type. Several possibilities may explain how the known direct
effects of ARF6 activation lead to this altered morphology
and behavior.
ARF6 was originally characterized as a regulator of the
plasma membrane endocytosis and recycling system (for re-
view see Chavrier and Goud, 1999). In migrating cells, recy-
cling pathways are polarized towards the leading edge, which
may serve to efficiently recycle molecules involved in actin re-
organization and substrate attachment (i.e., integrins) to the
rapidly expanding leading edge (Nabi, 1999). Recruitment of
ARNO and subsequent activation of ARF6 at the free edge of
cells may polarize the recycling process, leading to an en-
hanced accumulation of actin-modifying proteins, matrix at-
tachment proteins or signaling molecules at the free edge.
Additionally, activation of ARFs can lead to significant
changes in the lipid composition of the local membrane. Spe-
cifically, at the plasma membrane, ARFs are known to di-
rectly activate two lipid-modifying enzymes, PLD and phos-
phatidylinositol-4-phosphate 5-kinase (Exton, 1997; Honda
et al., 1999). PLD cleaves phosphatidyl choline into PA,
thereby changing the charge of the bilayer surface and remov-
ing a bulky head group. PA can be further metabolized to
produce diacylglycerol or lysoPA, two molecules with well
known signal transduction properties (Exton, 1997). Addi-
tionally, PA is known to be a cofactor in the activation of a
PI-4P-5 kinase isoform (PI-4P-5K
 
 
 
) that is also allosterically
activated by ARF (Honda et al., 1999). In this study, we
show that expression of ARNO leads to increased production
of PA by PLD, and that inhibition of PLD activity with
1-butanol prevents formation of lamellipodia and cell migra-
tion. Although 1-butanol might be inhibiting another pro-
cess that is required for migration, at present no specific
inhibitors of PLD exist. The fact that t-butanol has no effect
on ARNO-induced morphology suggests that butanol is
indeed inhibiting these changes via inhibition of PLD.
Whether this is due to inhibition of PA production, PA-
dependent phosphatidylinositol 4,5 bisphosphate synthesis,
or the production of other PA metabolites, remains to be de-
termined.
 
Rac activation by ARF
 
Numerous studies have established a requirement for Rac
activation in cell motility. In the context of a wound-healing
assay, microinjection of dominant negative Rac1 constructs
into either MDCK cells (Fenteany et al., 2000) or rat em-
bryo fibroblasts (Nobes and Hall, 1999) has been shown to
inhibit both the formation of lamellipodia and migration of
cells into the wound. Here, we demonstrate that expression
Figure 8. Inhibition of PLD activity 
prevents morphological changes in-
duced by ARNO. MDCK cells were in-
fected with ARNO-encoding adenovirus 
for 90 min. Further expression was pre-
vented by the addition of 20 ng/ml doxy-
cycline. Cells were incubated for another 
90 min in the absence of butanol (A and 
B) or in the presence of 0.5% 1-butanol 
(C and D) or 0.5% tert-butanol (E and F). 
Cells were then fixed and stained with 
9E10 monoclonal anti-myc (B, D, and F) 
to label ARNO and rhodamine-phalloi-
din (A, C, and E) to label filamentous ac-
tin. Asterisks indicate ARNO-expressing 
cells. Bar, 50  m. 
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of ARNO in MDCK cells leads to increased activation of
endogenous Rac1, and that dominant negative N17Rac pre-
vents induction of the migratory phenotype by ARNO.
Taken together, these data suggest that Rac1 functions
downstream of ARF6 in a GTPase cascade. To our knowl-
edge, this is the first direct demonstration of endogenous
Rac activation by a pathway involving ARF.
How does ARF6 activation lead to activation of Rac? Sev-
eral studies have suggested that Rac1 is enriched in mem-
branes of the endosomal system and that this endosomal
pool of Rac can be translocated to the plasma membrane as a
result of ARF6 activation (Radhakrishna et al., 1999; Bo-
shans et al., 2000). Additionally, these studies demonstrated
that dominant negative ARF6 T27N can block ruffling in-
duced by Rac. However, another study demonstrated that
dominant negative ARF6 could block ruffling induced by a
Rac construct that was constitutively localized to the plasma
membrane, suggesting a role for ARF6 independent of the
control of Rac localization (Zhang et al., 1999). None of
these studies directly examined the activation state of endog-
enous Rac; therefore, the precise role of ARF6-mediated lo-
calization in the activation of Rac has remained unclear.
A second possibility is that ARF-induced changes in the
membrane phospholipid composition create a local environ-
ment conducive to Rac activation. In opposition to this
model, we found that inhibition of PLD-mediated PA pro-
 
duction does not prevent activation of Rac. Under the same
experimental conditions, morphological changes induced by
ARNO are strongly inhibited. Taken together, these data
suggest that ARF-mediated Rac activation occurs indepen-
dently of ARF-mediated lipid modification, but that both
are required to regulate actin structure and cell motility.
Consistent with this model, whereas activation of Rac is re-
quired for spreading and ruffling of MDCK cells in response
to hepatocyte growth factor, injection of constitutively ac-
tive Rac into MDCK cells induces membrane ruffling but
not motility (Ridley et al., 1995). These observations com-
bine to suggest that signals in addition to Rac activation are
needed to convert MDCK cells to a migratory state and that
ARF-mediated activation of PLD can provide at least some
of these signals.
Another potential mechanism for the activation of Rac
downstream of ARNO is the recruitment of a Rac-GEF in
response to ARF-GTP. Recently, multiple proteins contain-
ing ARF GTPase–activating (GAP) domains have been iden-
tified. These proteins possess other domains involved in
protein–protein interactions, such as ankyrin repeats, PH
domains, proline-rich domains, or SH3 domains, suggesting
that they may participate in the formation of large, multipro-
tein complexes (Donaldson and Jackson, 2000). The sub-
family of ARF-GAPs, consisting of Git1, p95Pkl, and
p95APP1, have been shown to associate directly with the
Rac exchange factor PIX (also known as COOL) (Bagrodia
et al., 1999; Turner et al., 1999; Di Cesare et al., 2000; Zhao
et al., 2000). All three of these proteins are localized to focal
adhesions and bind to paxillin, further implicating this fam-
ily of proteins in the regulation of cortical actin organization,
cell adhesion, and migration (Turner et al., 1999; Di Cesare
et al., 2000; Zhao et al., 2000). Moreover, overexpression of
both GIT1 and APP1 cause a loss of paxillin from focal ad-
hesions (Di Cesare et al., 2000; Zhao et al., 2000).
These observations suggest one possible model for the ac-
tivation of Rac downstream of ARF-GTP in which binding
of ARF-GTP to GIT, Pkl, or APP1 leads to the assembly of
a complex containing GIT–Pkl–APP and PIX and the sub-
sequent local activation of Rac. Consistent with the possible
existence of such a complex, GIT1, PIX, and paxillin colo-
calize with ARNO in the broad lamellipodia seen in migra-
tory MDCK cells (data not shown). Whether the assembly
of this complex is directly modulated by ARF remains to be
determined.
In this scenario, the GIT family proteins would be acting
not only as GAPs to terminate further ARF signaling, but
also as effectors downstream of ARF-GTP to enhance Rac
activation. Recent evidence indicates that the distinction be-
tween G-protein GAPs and effectors is less clear cut than
originally conceived. For example, phospholipase C, ade-
nylyl cyclase, and p115-RhoGEF are effector proteins for
heterotrimeric G-proteins that have also been shown to pos-
sess GAP activity towards these same G-proteins (Montell,
2000). This combination of GAP and effector activity ap-
pears likely to apply to the ARF GAPs as well.
The role of Rac in the regulation of epithelial structure
and motility is complex. Rac activation is required for the
formation and maintenance of cell–cell junctions in epithe-
lial monolayers (Hordijk et al., 1997; Takaishi et al., 1997;
Figure 9. Inhibition of PLD does not prevent activation of Rac by 
ARNO. MDCK cells were infected with adenovirus encoding ARNO 
for 2 h. Cells were incubated for an additional hour in the presence 
or absence of 0.5% 1-butanol or tert-butanol. Cells were then lysed 
and GTP-Rac isolated as described in Materials and methods. Data 
are representative of four separate experiments. 
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Jou and Nelson, 1998). Along the same lines, in MDCK
cells that have adopted a mesenchymal phenotype in re-
sponse to coexpression of oncogenic Ras, expression of the
Rac exchange factor Tiam1 induces a reversion to an epithe-
lial phenotype (Hordijk et al., 1997; Zondag et al., 2000).
In established epithelia, on the other hand, activation of Rac
is required for the adoption of a motile state in response to
growth factors such as HGF or in response to wounding
(Ridley et al., 1995; Gimond et al., 1999; Fenteany et al.,
2000). These data combine to suggest that the location and
precise levels of active Rac may play a critical role in the
structure and motility of epithelial cells.
Although the acquisition of motility by epithelial cells re-
quires the activation of Rac, activated Rac alone is not suffi-
cient to induce motility in these cells (Ridley et al., 1995;
Jou and Nelson, 1998; Gimond et al., 1999). This has led to
the suggestion that activation of another signaling path-
way(s) is required for this transition (Ridley et al., 1995; Gi-
mond et al., 1999; Zondag et al., 2000). We have found
that activation of ARF via expression of the exchange factor
ARNO is sufficient to induce motility in MDCK cells. This
transformation requires downstream activation of both Rac
and PLD, which presumably then function in concert to
regulate actin structure and cell motility. Activation of ARF
proteins provides one mechanism whereby these cells can
engineer a localized production of active Rac associated with
phospholipid modifications, thereby enhancing their migra-
tory potential.
 
Materials and methods
 
Reagents, antibodies, and DNA constructs
 
The following antibodies were used: mouse anti-myc 9E10, rabbit anti-HA
(BabCo), mouse anti-Rac (clone 102; BD Transduction Laboratories), poly-
clonal anti-ARNO (Frank et al., 1998a). Monoclonal mouse anti-ARNO
(6G11). Monoclonal mouse anti-ARF6 8A6-2 (used for Western blots) and
rabbit anti-ARF1 (used for immunofluorescence) were gifts from Sylvain
Bourgoin (Laval University, Ste-Foy, Canada), rabbit anti-ARF6 (for immu-
nofluorescence) was obtained from Victor Hsu (Harvard Medical School,
Boston, MA) and rabbit anti-ARF1 (for Western blot) was obtained from
Paul Melancon (University of Alberta, Edmonton, Canada). Cy2-donkey
anti–mouse, Cy2-donkey anti–rabbit, Texas red goat anti–mouse, and
Texas red donkey anti–rabbit were obtained from Jackson ImmunoRe-
search. Rhodamine-conjugated phalloidin was from Molecular Probes.
Horseradish peroxidse–coupled sheep anti–mouse and goat anti–rabbit
secondary antibodies (Amersham Pharmacia Biotech) were used for West-
ern blotting.
Recently, it has been demonstrated that ARNO and its relatives each ex-
ist in two splice isoforms which produce PH domains with differing affini-
ties for PI-(3,4,5)P
 
3
 
 and PI-(4,5)P
 
2
 
 (Klarlund et al., 2000). In this study, we
used the isoform of ARNO (GGG, tri-gly), which has equivalent affinities
for the two inositol lipid moieties.
The construct pGST-GGA3
 
VHS-GAT
 
 (Dell’Angelica et al., 2000) encoding
the VHS and ARF binding domains of GGA3 fused to GST was obtained
from Paul Randazzo and Juan Bonifacino (National Institutes of Health,
Bethesda, MD).
Oleic acid (9,10-
 
3
 
H[N]) (5 mCi/ml, 5–15 Ci/mmol) was obtained from
NEN Life Science Products. Fibronectin was purchased from Becton Dick-
inson. Tissue culture reagents were purchased from GIBCO BRL.
 
Tissue culture
 
The T23 line of MDCK cells, which expresses the tetracycline-repressible
transactivator (Barth et al., 1997), was maintained in DME with 4.5 g/L glu-
cose, 10% FBS, and antibiotics in a 37
 
 
 
C, 5% CO
 
2
 
 incubator. A clone of
these cells expressing N17 Rac under control of the tetracycline-respon-
sive promoter (Jou and Nelson, 1998) was grown in the same manner, with
the addition of 20 ng/ml doxycycline to repress transgene expression.
 
Transient transfections were performed using the fugene 6 reagent (Roche)
according to the manufacturer’s instructions.
For immunofluorescence, cells (5
 
   
 
10
 
4
 
 cells) were plated on glass cov-
erslips in 35-mm dishes 38–44 h before the experiment. Monolayers for
wound healing experiments were formed by plating 10
 
6
 
 cells in 35-mm
dishes 40–48 h before wounding. For Rac and ARF (5
 
   
 
10
 
5
 
 cells) GTPase
activation assays and for PLD assays (2.5
 
   
 
10
 
5
 
 cells) cells were plated in
35-mm wells 18 h before the experiment. Finally, for transwell migration
assays 2.5
 
   
 
10
 
6
 
 cells were plated in 60-mm dishes 18 h before the initia-
tion of the experiment.
 
Adenovirus-mediated expression
 
The recombinant adenoviruses used to express exogenous myc-tagged
ARNO proteins under the control of the tetracycline regulatable transacti-
vator have been described previously (Frank et al., 1998b; Altschuler et al.,
1999). For morphological and GTPase activation experiments, cells were
infected in serum free DME for 2.5–3 h. For wound healing assays, mono-
layers of cells were infected for 1.5 h in Hank’s Balanced Salt Solution
(HBSS
 
 
 
) without divalent cations (GIBCO BRL) in the presence of 20 ng/ml
doxycycline to repress transgene expression. Monolayers were recovered
overnight in DME with 10% FBS and either 20 ng/ml doxycycline (ARNO-
expressing cells) or 0.2 ng/ml doxycycline (ARF6 T27N cells). The doxycy-
cline was removed by washing with fresh DME and monolayers were incu-
bated for 2–3 h to allow expression of the transgene before wounding. In
all cases control cells were infected in the same manner, but were contin-
uously maintained in 20 ng/ml doxycycline to prevent transgene expres-
sion.
 
Immunofluorescence microscopy
 
Cells were infected with recombinant adenovirus as described above, then
fixed with 4% paraformaldehyde in PBS, and processed for indirect immu-
nofluorescence as described previously (Frank et al., 1998b). Cells were
observed and photographed using a microscope (Eclipse E800; Nikon)
equipped with a Diagnostic Instruments spot digital camera. Images were
recorded using Adobe Photoshop
 
®
 
.
 
Transwell migration assay
 
Migration was assessed using modified Boyden chambers containing Trans-
well filters (6.5-mm diameter, 8-
 
 
 
m pores; Costar) coated on the under-
side with 5 
 
 
 
g/cm
 
2
 
 fibronectin. T23 cells were infected with recombinant
adenovirus in HBSS
 
 
 
 for 2 h as described above. Cells were then allowed
to recover for 2 h in DME with 10% FBS, then were harvested by incuba-
tion in PBS with 1 mM EGTA, 4 mM EDTA, and then resuspended in Opti-
mem (GIBCO BRL), 10 mM Hepes, pH 7.4, and 0.1% heat-denatured BSA.
Cells (2
 
   
 
10
 
5
 
) were added to the upper chamber of the Transwell filter,
with the same buffer located in the lower chamber. After migration for
16 h, cells remaining on the upper surface of the filter were removed with
a cotton swab. Cells on the lower side were fixed with 3.7% formaldehyde
and stained with 0.1% crystal violet. The dye was extracted into 1% so-
dium deoxycholate and quantitated by measuring the optical density at
590 nm.
 
Wound healing
 
Monolayers of cells were infected with recombinant adenovirus and in-
duced to express as described above. Monolayers were wounded by
scraping with a teflon cell scraper, rinsed several times with media to re-
move dislodged cells, and placed back into DME with 10% FBS containing
2 ng/ml doxycycline to limit further transgene expression. Cells were incu-
bated at 37
 
 
 
C under 5% CO
 
2
 
 while migration of the monolayer into the
cleared wound area was recorded using a PDMI-2 stage incubator (Har-
vard Instruments) on a microscope (IX-70; Olympus) outfitted with Hoff-
man optics. Digital images were collected every minute for 4 h using a
Hamamatsu Orca camera. The area covered by the monolayer was traced
and measured using OpenLab 2.0 software (Improvision).
 
G-protein pull down assays
 
Activation levels of endogenous Rac were assayed in cells infected with
ARNO-expressing adenoviruses as described above. Endogenous GTP-Rac
was isolated by incubation with a GST fusion to the PBD domain of PAK
and quantitated as described previously (Criss et al., 2001).
Activation of endogenous ARFs by ARNO expression was assayed using
a novel pulldown assay. Cells were infected with ARNO-expressing ade-
noviruses in serum-free DME in the presence or absence of doxycycline as
described above for 2 h. 20 ng/ml doxycycline was then added and the
cells were incubated for an additional hour. Extensive ruffling and migra-
tion of the ARNO-expressing cells was apparent at this point. Cells were 
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then lysed at 4
 
 
 
C in 0.65 ml of 50 mM Tris, pH 7.5, 100 mM NaCl, 2 mM
MgCl
 
2
 
, 0.1% SDS, 0.5% sodium deoxycholate, 1% Triton X-100, 10%
glycerol with 0.1 mM PMSF and 1 
 
 
 
g/ml each pepstatin, leupeptin, and
antipain. Lysates were clarified by centrifugation at 16 g for 2 min in the
presence of CL-4B Sepharose beads (Amersham Pharmacia Biotech). 0.5
ml of the clarified lysate was incubated with 40  g of GST-GGA3 bound to
glutathione-Sepharose beads (Amersham Pharmacia Biotech) for 30 min.
The beads were then washed three times with 50 mM Tris, pH 7.5, 100
mM NaCl, 2 mM MgCl2, 1% NP-40, 10% glycerol with 0.1 mM PMSF, and
1  g/ml each of pepstatin, leupeptin, and antipain. Bound proteins were
eluted into 60  l SDS-PAGE sample buffer. This sample was divided (15  l
for ARF1 and 40  l for ARF6) and assayed for the presence of endogenous
ARF1 and ARF6 by Western blotting with ARF1- and ARF6-specific anti-
bodies. Total levels of each ARF in the starting lysates were assayed by
Western blotting of 3% of the clarified lysate.
PLD assay
Cellular lipids in T23 MDCK cells were labeled by incubation in Opti-
mem, 0.5% FBS, and 1  Ci/ml 
3H-oleic acid for 18–24 h. Cells were then
infected with adenovirus for 3 h in serum-free Optimem. Butanol was
added to 0.3% and incubation continued for an additional 30 min. Cellu-
lar lipids were isolated by extraction with chloroform/methanol and sepa-
rated by TLC on Silca gel plates with H2O-saturated ethyl acetate/isooc-
tane/acetic acid (55:25:10). Phosphatidylbutanol was identified by
comigration with an unlabeled standard and quantitated by liquid scintilla-
tion counting.
Online supplemental material
Time lapse videos of the wound healing assays shown in Fig. 3 are pro-
vided as supplemental videos. Three videos are provided showing migra-
tion of the monolayer into the cleared wound area of control cells (Video
1), ARNO-expressing cells (Video 2), and cells expressing the E156K-
S392A mutant of ARNO (Video 3). The videos were recorded as described
above. A frame was recorded every minute for 4 h and QuickTime movies
were produced using the program OpenLab. Supplementary videos are
available at www.jcb.org/cgi/content/full/200104019/DC1.
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